Cargando…

Low-Value Prostate-Specific Antigen Screening in Older Males

IMPORTANCE: The US Preventive Services Task Force guidelines advise against prostate-specific antigen (PSA) screening for prostate cancer in males older than 69 years due to the risk of false-positive results and overdiagnosis of indolent disease. However, this low-value PSA screening in males aged...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kalavacherla, Sandhya, Riviere, Paul, Javier-DesLoges, Juan, Banegas, Matthew P., McKay, Rana R., Murphy, James D., Rose, Brent S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Medical Association 2023
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10091155/ https://www.ncbi.nlm.nih.gov/pubmed/37040113 http://dx.doi.org/10.1001/jamanetworkopen.2023.7504

Ejemplares similares

Association of Prostate-Specific Antigen Velocity With Clinical Progression Among African American and Non-Hispanic White Men Treated for Low-Risk Prostate Cancer With Active Surveillance
por: Nelson, Tyler J., et al.
Publicado: (2021)

EDITORIAL COMMENT
por: Javier-DesLoges, Juan, et al.
Publicado: (2022)

Association Between Primary Care Use Prior to Cancer Diagnosis and Subsequent Cancer Mortality in the Veterans Affairs Health System
por: Qiao, Edmund M., et al.
Publicado: (2022)

Evaluation of Insurance Coverage and Cancer Stage at Diagnosis Among Low-Income Adults With Renal Cell Carcinoma After Passage of the Patient Protection and Affordable Care Act
por: Javier-DesLoges, Juan F., et al.
Publicado: (2021)

Disparities in germline testing among racial minorities with prostate cancer
por: Weise, Nicole, et al.
Publicado: (2021)

Analysis of CDK12 alterations in a pan‐cancer database
por: Pan, Elizabeth, et al.
Publicado: (2021)

Low-Value Prostate-Specific Antigen Test for Prostate Cancer Screening and Subsequent Health Care Utilization and Spending
por: Kim, David D., et al.
Publicado: (2022)

Disparities in Telemedicine Utilization for Urology Patients During the COVID-19 Pandemic
por: Javier-DesLoges, Juan, et al.
Publicado: (2022)

Evaluation of the Use of Cancer Registry Data for Comparative Effectiveness Research
por: Kumar, Abhishek, et al.
Publicado: (2020)

Association of Treatment With 5α-Reductase Inhibitors and Prostate Cancer Mortality Among Older Adults
por: Kumar, Abhishek, et al.
Publicado: (2019)

Assessment of Care Cascades Following Low-Value Prostate-Specific Antigen Testing Among Veterans Dually Enrolled in the US Veterans Health Administration and Medicare Systems
por: Pickering, Aimee N., et al.
Publicado: (2022)

The Importance of Prostate-Specific Membrane Antigen Expression in Carotid Body Paragangliomas
por: Yasan, Hasan, et al.
Publicado: (2021)

The Importance of Prostate-Specific Membrane Antigen Expression in Salivary Gland Tumors
por: Sivrice, Mehmet Emre, et al.
Publicado: (2022)

Racial and Ethnic Disparities in the Use of Prostate Magnetic Resonance Imaging Following an Elevated Prostate-Specific Antigen Test
por: Abashidze, Nino, et al.
Publicado: (2021)

Association of the USPSTF Grade D Recommendation Against Prostate-Specific Antigen Screening With Prostate Cancer–Specific Mortality
por: Burgess, Laura, et al.
Publicado: (2022)

Variation in Prostate-Specific Antigen Testing Rates and Prostate Cancer Treatments and Outcomes in a National 20-Year Cohort
por: Bergengren, Oskar, et al.
Publicado: (2021)

Cost-Effectiveness of Annual Prostate MRI and Potential MRI-Guided Biopsy After Prostate-Specific Antigen Test Results
por: Yun, Hyunkyung, et al.
Publicado: (2023)

Association Between Antidiabetic Medications and Prostate-Specific Antigen Levels and Biopsy Results
por: Beckmann, Kerri, et al.
Publicado: (2019)

Obesity inversely correlates with prostate-specific antigen levels in a population with normal screening results of prostate cancer in northwestern China
por: Zhang, J., et al.
Publicado: (2016)

Variations in Age-Adjusted Prostate Cancer Incidence Rates by Race and Ethnicity After Changes in Prostate-Specific Antigen Screening Recommendation
por: Lai, Sue-Min, et al.
Publicado: (2022)

Treatment Intensification for Low-risk Metastatic Hormone-sensitive Prostate Cancer: The Time Is Now
por: McKay, Rana R.
Publicado: (2022)

Updates in the management of unknown primary of the head and neck
por: Kalavacherla, Sandhya, et al.
Publicado: (2022)

Prostate-Specific Membrane Antigen Expression on PET/CT in Patients with Metastatic Castration-Resistant Prostate Cancer: A Retrospective Observational Study
por: Calderoni, Letizia, et al.
Publicado: (2023)

Risk of Short-Term Prostate-Specific Antigen Recurrence and Failure in Patients With Prostate Cancer: A Secondary Analysis of a Randomized Clinical Trial
por: Sayan, Mutlay, et al.
Publicado: (2023)

(177)Lu-Prostate-Specific Membrane Antigen Therapy in Patients with Metastatic Castration-Resistant Prostate Cancer and Prior (223)Ra (RALU Study)
por: Rahbar, Kambiz, et al.
Publicado: (2023)

Impact of age on treatment response in men with prostate cancer treated with radiotherapy
por: Bryant, Alex K., et al.
Publicado: (2021)

Underlying Subclavian Artery Occlusion Initially Misdiagnosed in Weightlifter Using Anabolic Steroids: A Case Report and Review of Literature
por: Meller, Leo, et al.
Publicado: (2023)

Biomarker-Directed Therapy in Black and White Men With Metastatic Castration-Resistant Prostate Cancer
por: Hwang, Clara, et al.
Publicado: (2023)

Development of a Metric to Detect and Decrease Low-Value Prescribing in Older Adults
por: Radomski, Thomas R., et al.
Publicado: (2022)

Blood type B antigen is associated with worse New York Heart Association classification in male patients with hypertrophic cardiomyopathy
por: Jiang, Xiaowei, et al.
Publicado: (2018)

Quantitative trait loci controlling agronomic and biochemical traits in Cannabis sativa
por: Woods, Patrick, et al.
Publicado: (2021)

Performance of a Prostate-Specific Membrane Antigen Positron Emission Tomography/Computed Tomography–Derived Risk-Stratification Tool for High-risk and Very High-risk Prostate Cancer
por: Xiang, Michael, et al.
Publicado: (2021)

Male health: is prostate specific antigen alone useful?
Publicado: (2023)

Preferences for More or Less Health Care and Association With Health Literacy of Men Eligible for Prostate-Specific Antigen Screening in Australia
por: Pickles, Kristen, et al.
Publicado: (2021)

Association of Increased Prostate-Specific Antigen Levels After Treatment and Mortality in Men With Locally Advanced vs Localized Prostate Cancer: A Secondary Analysis of 2 Randomized Clinical Trials
por: King, Martin T., et al.
Publicado: (2021)

What do older people value when they visit their general practitioner? A qualitative study
por: Marcinowicz, Ludmila, et al.
Publicado: (2014)

Factors Important to Older Adults Who Disagree With a Deprescribing Recommendation
por: Weir, Kristie Rebecca, et al.
Publicado: (2023)

Association of Baseline Prostate-Specific Antigen Level With Long-term Diagnosis of Clinically Significant Prostate Cancer Among Patients Aged 55 to 60 Years: A Secondary Analysis of a Cohort in the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial
por: Kovac, Evan, et al.
Publicado: (2020)

Dissatisfaction and acne vulgaris in male adolescents and associated factors()
por: Isaacsson, Viviane Christina Siena, et al.
Publicado: (2014)

Male and female recombination landscapes of diploid Arabidopsis arenosa
por: Dukić, Marinela, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_p2943movh20qvc7qcraak10qja